1. Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation
- Author
-
Kerensa Broersen, Ellen Hubin, Philip B. Verghese, Nico A. J. van Nuland, Nanobiophysics, and Applied Stem Cell Technologies
- Subjects
Gene isoform ,Apolipoprotein E ,medicine.medical_specialty ,UT-Hybrid-D ,Biophysics ,Lipid-anchored protein ,high-density lipoprotein ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Apolipoproteins E ,High-density lipoprotein ,Structural Biology ,In vivo ,Internal medicine ,Genetics ,medicine ,Humans ,Allele ,Molecular Biology ,Research Articles ,apolipoprotein E ,030304 developmental biology ,0303 health sciences ,030302 biochemistry & molecular biology ,aggregation ,isoform ,Cell Biology ,Alzheimer's disease ,In vitro ,Endocrinology ,chemistry ,Liposomes ,high‐density lipoprotein ,lipids (amino acids, peptides, and proteins) ,Protein Multimerization ,Lipoproteins, HDL ,lipidation ,Research Article ,Lipoprotein - Abstract
Apolipoprotein E (APOE) genotype determines Alzheimer's disease (AD) susceptibility, with the APOE ε4 allele being an established risk factor for late‐onset AD. The ApoE lipidation status has been reported to impact amyloid‐beta (Aβ) peptide metabolism. The details of how lipidation affects ApoE behavior remain to be elucidated. In this study, we prepared lipid‐free and lipid‐bound ApoE particles, mimicking the high‐density lipoprotein particles found in vivo, for all three isoforms (ApoE2, ApoE3, and ApoE4) and biophysically characterized them. We find that lipid‐free ApoE in solution has the tendency to aggregate in vitro in an isoform‐dependent manner under near‐physiological conditions and that aggregation is impeded by lipidation of ApoE.
- Published
- 2019
- Full Text
- View/download PDF